newsfilter
← Latest News
GlobeNewswire·

Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights

Highlights Focused as a pure-play drug discovery and development biotechnology company Primary work on the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative diseases for Rett Syndrome ("Rett"), CDKL5 Deficien